Bridelia atroviridis
Bridelia atroviridis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Bridelia atroviridis is a botanical species recognized for its significant therapeutic potential in traditional medicine. Research indicates that the plant possesses potent antiplasmodial activities, making it a subject of interest for combating infectious diseases. Specifically, the aqueous and hydroethanolic extracts derived from its leaves have shown effectiveness in addressing conditions such as malaria and parasitemia. Furthermore, studies suggest its utility in managing related hematological issues, including anemia and leukocytosis. Consequently, this plant serves as a vital natural resource in the search for effective treatments against parasitic infections.
- Synonyms
- Bridelia Zenkeri
- Common names
- Not available
- Family
- Phyllanthaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Synonyms
Bridelia atroviridis is a distinctive botanical species that plays an important role in its native ecosystem. In many scientific records, this plant is also identified by its synonym, Bridelia zenkeri. Understanding these nomenclatural connections is essential for researchers studying plant taxonomy and distribution. Recognizing both names ensures that botanical data remains accurate and consistent across various databases. Consequently, documenting these relationships helps clarify the complex history of the species' classification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Bridelia atroviridis is a fascinating specimen that belongs to the vast kingdom Plantae. Within this kingdom, it is specifically classified under the class Equisetopsida. It further belongs to the diverse order Malpighiales, showcasing its evolutionary connections. This plant is a prominent member of the genus Bridelia, which defines its unique morphological characteristics. Finally, it is nested within the family Phyllanthaceae, completing its complex botanical lineage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Phyllanthaceae |
| Genus | Bridelia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Bridelia atroviridis is a plant species primarily distributed throughout the diverse landscapes of the African continent. It is commonly found within the East Tropical Africa region, spanning across Kenya, Tanzania, and Uganda. The species also extends its reach into Northeast Tropical Africa, where it thrives in Ethiopia. Furthermore, its natural habitat includes the areas encompassing Sudan and South Sudan. This widespread presence highlights the plant's adaptability to various tropical environments across East and Northeast Africa.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Bridelia atroviridis is a self-supporting tree characterized by its distinct growth form. This species typically reaches a maximum height of approximately 6.1 meters in most environments. However, under optimal conditions, the plant can grow even taller, reaching a peak of about 8.33 meters. Such structural versatility allows it to establish a sturdy presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Bridelia atroviridis has demonstrated significant antiplasmodial activity, offering a promising natural alternative for malaria treatment. Research into the hydroethanolic bark extract reveals that it effectively combats chloroquine-resistant strains of Plasmodium falciparum in vitro. Furthermore, in vivo studies show that the plant extract significantly reduces parasitemia in infected subjects while maintaining low cytotoxicity. Beyond its direct antiparasitic effects, the extract helps prevent complications such as anemia and organ impairment by improving antioxidant status and reducing inflammation. These findings strongly support the traditional medicinal use of Bridelia atroviridis in managing malaria disease.
Compounds
Conditions
Bridelia atroviridis demonstrates significant medicinal potential by treating Plasmodium berghei-infected rats through reduced parasitemia. The plant extract effectively prevents anemia and manages leukocytosis in infected subjects. It further assists in treating liver and kidneys impairment by decreasing critical biochemical markers like transaminases and creatinine. Additionally, the extract improves the anti-inflammatory status of the body by decreasing pro-inflammatory cytokine levels. These combined therapeutic actions justify the plant's use in managing malaria and its associated complications.
Preparations
Bridelia atroviridis is prepared as an aqueous extract from its leaves to study its potent uterotonic effects on rat uterine contractions. This aqueous preparation works through complex cellular mechanisms involving calcium mobilization and G-protein activation. Additionally, Bridelia atroviridis is prepared as a hydroethanolic bark extract to evaluate its medicinal properties. The hydroethanolic extract has demonstrated significant in vitro and in vivo antiplasmodial activity against malaria. This specific hydroethanolic formulation also helps prevent anemia and organ impairment in infected subjects.
Parts used
Bridelia atroviridis is a small African tree that holds significant pharmacological potential due to its unique biological properties. Research has specifically focused on the aqueous extract derived from the plant's leaf to study its physiological effects. Scientific investigations reveal that this leaf extract exerts a potent uterotonic action by inducing contractions in the rat uterus. The study demonstrates that these contractions occur through complex mechanisms involving both intracellular and extracellular calcium mobilization. Ultimately, the medicinal value of the Bridelia atroviridis leaf is linked to its ability to activate specific G-protein pathways.